CAUSE WE'RE NOT GETTING ANY YOUNGER
LIVE

Serial Number

98747318

Owner

Senotherapeutix, Inc.

Attorney

Jared L. DuJack

Filing Date

Sep 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CAUSE WE'RE NOT GETTING ANY YOUNGER Trademark

Serial Number: 98747318

CAUSE WE'RE NOT GETTING ANY YOUNGER is a trademark filed by Senotherapeutix, Inc. on September 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Senotherapeutix, Inc. (15 trademarks)

9511 Collins Avenue #1403
Surfside, FL 33154

Entity Type: 03

Trademark Details

Filing Date

September 12, 2024

Registration Date

Not Registered

Published for Opposition

June 30, 2026

Goods & Services

Anti-aging therapy in the nature of treatment of age-related conditions; Anti-aging services, namely treatment of age-related conditions; Anti-aging therapy in the nature of treatment to improve longevity; Medical services; Medical services, namely, anti-aging services in the nature of treatment of age-related condition; Medical services, namely, treatment of age-related disorders; Medical services in the nature of treatment to improve longevity; Healthcare consulting services in the fields of longevity and age-related conditions; Medical and pharmaceutical consultation services in the fields of improving longevity and treating age-related conditions; Medical advisory services; Medical advisory services in the field of anti-aging; Medical advisory services in the field of prevention and treatment of age-related disorders; Medical testing services; Medical testing services in the field of anti-aging; Medical testing services in the field of prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services in the nature of performing biopsies in the field of senescent cells; Medical testing services in the nature of performing biopsies in the field of disorders related to biologic age; Medical testing services in the nature of performing biopsies in the field of biological age scoring; Medical testing services in the nature of performing biopsies in the field of related to determining a number or percentage of senescent cells; Non-invasive medical testing services; Non-invasive medical testing services related to biologic age; Non-invasive medical testing services related to biological age scoring; Non-invasive medical testing services related to determining a number or percentage of senescent cells

Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics for age therapy and gene therapy; Biological research and analysis namely, biologic age scoring; Biological research and analysis, namely, statistical scoring to determine a biologic age score of a patient; Medical research Laboratory services; Medical research Laboratory services related to biologic age; Medical research Laboratory services related to biological age scoring; Medical research Laboratory services related to determining a number or percentage of senescent cells; Medical research services; Medical research services, in the field of anti-aging; Medical research services in the nature of treatment of age-related disorders

Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 25, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
May 5, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 5, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
May 5, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 5, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 4, 2026 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 4, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 4, 2026 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 4, 2025 GNFN
FINAL REFUSAL E-MAILED
Nov 4, 2025 GNFR
FINAL REFUSAL WRITTEN
Nov 4, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 30, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 30, 2025 XELR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 25, 2025 ASCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2025 NWOS
NEW APPLICATION ENTERED
Sep 12, 2024 NWAP